Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin vs Placebo as Add-on to Metformin XR in Type 2 Diabetes
NCT00683657Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Saxagliptin + Metformin with Placebo + Metformin (2 arms). Primary endpoint: Change From Baseline in 24-Hour Mean Weighted Glucose (MWG) at Week 4. Started Jul 2008; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00683657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00683657.